Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

FLT3 decreases the amount of CEBPA. 1 / 1

| 1

➶

reach

"Considering that all five cell lines expressed relatively high levels of C/EBPalpha, which were not up-regulated by MLN518 treatments (XREF_FIG and XREF_FIG; not depicted), it appears that the suppression of C/EBPalpha expression by mutated FLT3 is not a general mechanism of the differentiation block in human AML cell lines."

16446383

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...